City of Hope today announced that its subsidiary, Cancer Treatment Centers of America, will soon undergo a large-scale rebrand. This comes as a part of the next phase in the health system's integration with CTCA, which it acquired just under one year ago.
The CTCA locations will also begin functioning as nonprofit organizations, which City of Hope claims will allow it to increase its resources and in turn increase the number of patients who can benefit from the specialized care offered by its cancer centers.
"Through our acquisition of CTCA, City of Hope is now able to share its expertise to benefit a greater number of patients in even more communities, including our bone marrow transplant and immune effector cell therapy programs," Robert Stone, City of Hope's CEO, said in a press release shared with Becker's.
Additionally, City of Hope is reorganizing key leadership roles to better structure a foundation for the continued integration of CTCA with the City of Hope. In light of the restructure, the organization announced that Kevin Manemann will take the reins as its new executive vice president and chief integration officer. He will be charged with overseeing further integration efforts as part of City of Hope's ongoing expansion efforts nationwide.
Looking ahead, Mr. Stone told Becker's that City of Hope will focus on supporting "clinical consistency and the highest quality of care throughout the system" as further integration and expansion efforts are put into place.